文献速递冠心病外科瓣膜外科

慢性淋巴细胞白血病对心脏手术后结局与再入院的影响

Impact of Chronic Lymphocytic Leukemia on Outcomes and Readmissions After Cardiac Operations.
PubMed 文献 · Ann Thorac Surg · 2021-08-23

基于2010至2017年全国再入院数据库,纳入择期冠脉搭桥、瓣膜修复或置换的成年患者,比较有或无慢性淋巴细胞白血病(CLL)者的结局。倾向匹配后,CLL患者院内死亡率与围术期并发症相似,但输血更常见,且再入院更易由呼吸系统病因导致。

要点

  • CLL患者心脏手术后院内死亡率和围术期并发症与非CLL者相似。
  • CLL患者再入院更常见,呼吸系统病因贡献显著,需探索干预。

核心结论

  • CLL患者心脏手术后总体结局与非CLL者相似,但输血更频繁且再入院更常见。

研究设计与样本

  • 回顾性队列研究,利用2010至2017年全国再入院数据库,纳入择期冠脉搭桥、瓣膜修复或置换的成年患者,按CLL病史分层并行3:1倾向匹配。

主要发现

  • 估计1,250,882例心脏手术患者中0.23%有CLL诊断。
  • CLL患者再入院更常见,呼吸系统病因显著贡献于再住院。

临床怎么用

  • 对此类CLL患者可考虑血液保护干预以改善结局。
  • 针对再入院的干预措施值得进一步探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Outcomes of cardiac operations in patients with chronic lymphocytic leukemia (CLL) have been examined in limited series. The present study aimed to assess the impact of CLL on clinical outcomes and resource utilization after cardiac operations in a nationally representative cohort. METHODS: All adult patients undergoing elective coronary artery bypass grafting, valve repair, or valve replacement were identified utilizing the 2010 to 2017 Nationwide Readmissions Database. Patients were stratified by history of CLL. Incidence of in-hospital mortality, perioperative complications, blood transfusions, and readmission within 90 days were examined. We subsequently performed 3:1 nearest neighbor matching between CLL and non-CLL patients for all primary and secondary outcomes of interest. RESULTS: Of an estimated 1,250,882 patients undergoing cardiac operations, 0.23% had a diagnosis of CLL. Among 11,237 propensity matched patients, those with CLL had similar rates of in-hospital mortality (3.8% vs 2.6%; P = .08) and perioperative complications (33.4% vs 33.6%; P = .92) compared with their non-CLL counterparts. Although the incidence of infection was comparable (8.5% vs 9.4%; P = .38), CLL patients did require blood transfusions more frequently (33.7% vs 28.4%; P = .003) than others. Furthermore, CLL patients were more likely to be readmitted with respiratory etiologies contributing significantly to rehospitalization. CONCLUSIONS: Patients with CLL generally have similar outcomes after cardiac operations but may more commonly require blood transfusion. Blood-conserving interventions may be considered in this at-risk population to improve outcomes. Furthermore, interventions to mitigate readmission deserve further exploration.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Madrigal J, Tran Z, Hadaya J, et al. Impact of Chronic Lymphocytic Leukemia on Outcomes and Readmissions After Cardiac Operations. Ann Thorac Surg. 2021. PMID: 34437856. doi:10.1016/j.athoracsur.2021.07.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。